Adelantado Lacasa M,Portillo ME,Lobo Palanco J,Chamorro J,Ezpeleta Baquedano C .2022 .Molecular epidemiology of multidrug-resistant Pseudomonas aeruginosa acquired in a spanish intensive care unit: Using diverse typing methods to identify clonal types. , 10(9) : 1791.
Assefa M .2022 .Multi-drug resistant gram-negative bacterial pneumonia: Etiology, risk factors and drug resistance patterns. Pneumonia (Nathan), 14(1) : 4.
Brunker LB,Boncyk CS,Rengel KF,Hughes CG .2023 .Elderly patients and management in intensive care units (ICU): Clinical challenges. Clin. Interv, 18 : 93-112.
De Almeida Silva KCF,Calomino MA,Deutsch G,de Castilho SR,de Paula GR,Esper LMR,Teixeira LA .2017 .Molecular characterization of multidrugresistant (MDR) Pseudomonas aeruginosa isolated in a burn center. , 43(1) : 137-143.
Goto A,Komiya K,Umeki K,Hiramatsu K,Kadota JI K .2023 .Impact of Pseudomonas aeruginosa coverage on the prognosis of elderly patients with communityacquired pneumonia. J. Infect. Chemother., 29(1) : 55-60.
Hernández-Jiménez P,López-Medrano F,Fernández-Ruiz M,Silva JT,Corbella L,San-Juan R,Lizasoain M,DíazRegañón J,Viedma E,Aguado JM .2022 .Risk factors and outcomes for multidrug resistant Pseudomonas aeruginosa Infection in Immunocompromised patients. Antibiotics, 11(11) : 1459.
Ibrahim K,Thwood D,ELgheriani H,Salem M,Elgadiym Z,Zaghdani A,Alhudiri I,Habibi A,Elfahem A,Belaid S,Ermithi O,Almaghrabi M,ELmaryul A,Almadah S,Rayes A,El Meshri SE,El Salabi A,Elzagheid A .2024 .Prevalence of multi-drug resistant bacteria in intensive care units. Libyan J. Med, 19(1) : 2348235.
Kalın G,Alp E,Chouaikhi A,Roger C .2023 .Antimicrobial multidrug resistance: Clinical implications for infection management in critically Ill Patients. , 11(10) : 2575.
Kang JS,Moon C,Mun SJ,Lee JE,Lee SO,Lee S,Lee SH .2021 .Antimicrobial susceptibility trends and risk factors for antimicrobial resistance in Pseudomonas aeruginosa Bacteremia: 12-Year Experience in a Tertiary Hospital in Korea. J. Korean Med, 36(43) : .
Kiyaga S,Kyany' C,Muraya AW,Smith HJ,Mills EG,Kibet C,Mboowa G,Musila L G .2022 .Genetic diversity, distribution and genomic characterization of antibiotic resistance and virulence of Clinical Pseudomonas aeruginosa Strains in Kenya. , 13 : 835403.
Kresken M,Körber-Irrgang B,Korte-Berwanger M,Pfennigwerth N,Gatermann SG,Seifert H .2020 .Dissemination of carbapenem-resistant Pseudomonas aeruginosa isolates and their susceptibilities to ceftolozane-tazobactam in Germany. Int. J. Antimicrob. Agents, 55(6) : 105959.
Nasrin S,Hegerle N,Sen S,Nkeze J,Sen S,Permala-Booth J,Choi M,Sinclair J,Tapia MD,Johnson JK,Sow SO,Thaden JT,Fowler VG,Krogfelt KA,Brauner A,Protonotariou E,Christaki E,Shindo Y,Kwa AL,Shakoor S,Singh-Moodley A,Perovic O,Jacobs J,Lunguya O,Simon R,Cross AS,Tennant SM .2022 .Distribution of serotypes and antibiotic resistance of invasive Pseudomonas aeruginosa in a multi-country collection. BMC Microbiol, 22(1) : 13.
Pan D,Peng P,Fang Y,Lu J,Fang M .2022 .Distribution and drug resistance of pathogenic bacteria and prognosis in patients with septicemia bloodstream infection with renal insufficiency. Infect. Drug Resist, 15 : 4109-4116.
Paul M,Carrara E,Retamar P,Tängdén T,Bitterman R,Bonomo RA,de Waele J,Daikos GL,Akova M,Harbarth S,Pulcini C,Garnacho-Montero J,Seme K,Tumbarello M,Lindemann PC,Gandra S,Yu Y,Bassetti M,Mouton JW,Tacconelli E,Rodríguez-Baño J .2022 .European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine. Clin. Microbiol, 28(4) : 521-547.
.2022 .Chinese expert consensus on the management of lower respiratory tract infections of Pseudomonas aeruginosa in adults (. Zhonghua. Jie. He. He. Hu. Xi. Za. Zhi., 45(8) : 739-752.
Raman G,Avendano EE,Chan J,Merchant S,Puzniak L S .2018 .Risk factors for hospitalized patients with resistant or multidrug-resistant Pseudomonas aeruginosa infections: A systematic review and metaanalysis. Antimicrob. Resist. Infect. Control, 7 : 79.
.2025 .Chinese expert consensus on the diagnosis and treatment of pneumonia in the elderly (2024 Edition). Zhonghua. Jie. He. He. Hu. Xi. Za. Zhi., 48(1) : 18-34.
Reynolds D and Kollef M .2021 .The Epidemiology and pathogenesis and treatment of Pseudomonas aeruginosa infections: An Update. Drugs, 81(18) : 2117-2131.
Tang S,Xiao Y,Li J,Li D,Wu S,Huang X,Li J,Yang L,Li J,Wang T,Zhang G,Xu Y,Xie Y Y .2024 .Distribution and drug resistance characteristics of pathogenic bacteria in the elderly population in China in 2021. , 55(4) : 989-994.
Theodorakis N,Feretzakis G,Hitas C,Kreouzi M,Kalantzi S,Spyridaki A,Boufeas IZ,Sakagianni A,Paxinou E,Verykios VS,Nikolaou M .1978 .Antibiotic resistance in the elderly: Mechanisms, risk factors and solutions. , 12(10) : .
Van An N,Hoang LH,Le HHL,Thai Son N,Hong LT,Viet TT,Le TD,Thang TB,Vu LH,Nguyen VTH,Xuan Nguyen K VTH .2023 .Distribution and antibiotic resistance characteristics of bacteria isolated from blood culture in a teaching hospital in vietnam during 2014-2021. , 16 : 1677-1692.
Wang Z,Qin RR,Huang L,Sun LY .2018 .Risk factors for carbapenem-resistant Klebsiella pneumonia infection and mortality of Klebsiella pneumonia infection. Chin. Med. J. (Engl)., 131(1) : 56-62.
Yin C,Alam MZ,Fallon JT,Huang W .2024 .Advances in development of novel therapeutic strategies against multi-drug Resistant Pseudomonas aeruginosa. Antibiotics, 13(2) : 119.
Yin Y,Zhao C,Li H,Jin L,Wang Q,Wang R,Zhang Y,Zhang J,Wang H,CARES network H .2021 .Clinical and microbiological characteristics of adults with hospital-acquired pneumonia: A 10-year prospective observational study in China. Eur. J. Clin. Microbiol, 40(4) : 683-690.
Zhang S,Ou J,Tan Y,Yang B,Wu Y,Liu L Y .2023 .Metagenomic next-generation sequencing for pulmonary infections diagnosis in patients with diabetes. BMC Pulm. Med, 23(1) : 142.
Zhang Y,Li Y,Zeng J,Chang Y,Han S,Zhao J,Fan Y,Xiong Z,Zou X,Wang C,Li B,Li H,Han J,Liu X,Xia Y,Lu B,Cao B B .2020 .Risk factors for mortality of inpatients with Pseudomonas aeruginosa bacteremia in china: impact of resistance profile in the mortality. Infect. Drug Resist, 13 : 4115-4123.
Zhou C,Sun L,Li H,Huang L,Liu X .2023 .Risk factors and mortality of elderly patients with hospitalacquired pneumonia of carbapenem-resistant Klebsiella pneumoniae Infection. , 16 : 6767-6779.
Zhu Y,Huang WE,Yang Q .2022 .Clinical perspective of antimicrobial resistance in bacteria. Infect. Drug Resist, 15 : 735-746.